/

Empresas

An

No verificado

Anokion SA

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa

08/01/2025

Industria

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Anokion Announces Positive Symptom Data from its Phase 2 Trial Evaluating KAN-101 for the Treatment of Celiac Disease

Fuente

Editor

1.00

0

19/12/2024

Industria

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease

Fuente

Editor

1.00

0

18/09/2024

Eventos

Ferias y Congresos

Industria

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Anokion Announces New Data from the Phase 1 MoveS-it Study Supporting ANK-700 as a Novel, Potential Disease Modifying Treatment for Relapsing-Remitting Multiple Sclerosis

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0